Rarer Types Event Recordings – DE

EDS ECHO Veranstaltungsreihe: Seltenere Typen der Ehlers-Danlos- Syndrome

Allgemeine Einleitung (EDS, Differentialdiagnostik aller EDS-Typen.) – Prof. Fransiska Malfait
Ghent

After obtaining her university degree as a medical doctor in 2000, Fransiska Malfait performed a pre-doctoral training on the phenotypic characterization and identification of novel genetic defects in several subtypes of the Ehlers-Danlos syndrome (EDS). This resulted in a series of peer-reviewed publications and a PhD degree in medical sciences, with a thesis entitled, “New insights in the molecular pathogenesis of the Ehlers-Danlos syndrome.” Simultaneously, Dr. Malfait was also trained as a clinical geneticist and became involved in the genetic counseling and clinical care of patients with heritable connective tissue disorders (HCTD). Impressed by the chronic musculoskeletal problems and pain that patients with these conditions suffer from, she decided to further specialize in rheumatology, a degree she obtained in 2009. Her training as both a clinical geneticist and rheumatologist provided her the opportunity to develop a unique expertise in the diagnosis and management of patients with these conditions. 

Strategien und Tücken der Molekular-Analyse bei EDS – Prof. Johannes Zschocke
Innsbruck

Johannes Zschocke grew up in Cologne, Germany, and studied medicine in Freiburg im Breisgau, Germany, and Belfast, Northern Ireland. Since 2008 he is Professor and Chair of Human Genetics at the Medical University Innsbruck, Austria. As director of the Centre for Medical Genetics Innsbruck he is responsible for the provision of genetic services for the Western Austria and beyond. His current clinical and research focus is on inherited metabolic and connective tissue diseases.

Classical-like EDS (clEDS) & neue Typen – Dr. Serwet Demirdas
Rotterdam

Dr. Demirdas is a clinical geneticist at the Erasmus Medical Center in Rotterdam, The Netherlands, who has several publications concerning clEDS type 1 and other types of EDS. In her clinical practice she sees many patients with different types of EDS while working together with several disciplines through an established clinical pathway within the Erasmus Medical center. 

Q&A

Stimmen von innen – Nadéche Hanique – AEBP1
Netherlands

I’m Nadèche Hanique (24) and I’m from the Netherlands. I’m a psychology student specializing in medical and cognitive neuropsychology. I have the 14th type of EDS with a mutation on the AEBP1 gene. I’m very passionate about raising awareness for EDS, HSD and other conditions and disabilities. I also love advocating to improve inclusive education. 

EDS und Kollagen 1; inkl. Kardio-valvuläres EDS (cvEDS), Arthrochalasisches EDS (aEDS) – Dr. Anthony Vandersteen
Halifax

Diese Videopräsentation kann für eine begrenzte Zeit in unserer Whova-Event-App angesehen und nicht weiter geteilt werden. Das PDF dieser Präsentation kann über die Schaltfläche unten angezeigt und heruntergeladen werden.

Dr. Vandersteen is Associate Professor of Pediatrics / Medical Genetics at Dalhousie University and IWK Health Centre, Nova Scotia. 

Q&A

Dermatosparaxis EDS (dEDS) – Prof. Fransiska Malfait
Ghent

After obtaining her university degree as a medical doctor in 2000, Fransiska Malfait performed a pre-doctoral training on the phenotypic characterization and identification of novel genetic defects in several subtypes of the Ehlers-Danlos syndrome (EDS). This resulted in a series of peer-reviewed publications and a PhD degree in medical sciences, with a thesis entitled, “New insights in the molecular pathogenesis of the Ehlers-Danlos syndrome.” Simultaneously, Prof. Malfait was also trained as a clinical geneticist and became involved in the genetic counseling and clinical care of patients with heritable connective tissue disorders (HCTD). Impressed by the chronic musculoskeletal problems and pain that patients with these conditions suffer from, she decided to further specialize in rheumatology, a degree she obtained in 2009. Her training as both a clinical geneticist and rheumatologist provided her the opportunity to develop a unique expertise in the diagnosis and management of patients with these conditions. 

Q&A

Brittle Cornea Syndrome (BCS) Kyphoskoliotisches EDS (kEDS) – Dr. Marianne Rohrbach & Dr. Cecilia Giunta
Zürich

Diese Videopräsentation kann für eine begrenzte Zeit in unserer Whova-Event-App angesehen und nicht weiter geteilt werden.

Cecilia Giunta

I am a molecular geneticist and an established scientist working in the field of connective tissue disorders (CTD) since 1995.
In my scientific career, I have carried out pioneer research in different rare types of EDS such as kEDS, brittle cornea syndrome, aEDS and spEDS.  I have contributed to the development of comprehensive diagnostic procedures combining specific biochemical, cell-based and molecular genetic tools for the diagnosis of several types of EDS. 

Marianne Rohrbach

Education/Degrees 

1996 MD, Faculty of Medicine, University of Berne, and Swiss Federal Physician Diploma 

1999 PhD, molecular Genetics, Faculty of Medicine, University of Berne 

2007 Board Certified Pediatrician, FMH Kinder- und Jugendmedizin, Switzerland 

2007 Board Certified Medical Geneticist, FMH Medizinische Genetik, Switzerland 

2014 Habilitation, University of Zurich, Switzerland 

Employments 

2000 – 2003 Residency, University Children’s Hospital Berne, Prof. Dr. med. R. Kraemer, Switzerland 

2003 – 2004 Associate clinical specialist, University Children’s Hospital Berne, Prof. Dr. med. R. Kraemer, Switzerland 

2004 – 2006 “Postdoctoral fellowship” Division of Clinical and Metabolic Genetics, Prof. Dr. med. R. Weksberg, Hospital for Sick Children, Toronto, Canada 

2006 – 2007 Associate clinical specialist, Division of Clinical and Metabolic Genetics, Prof. Dr. med. J. Clark, Hospital for Sick Children, Toronto, Canada 

2007 – 2015 Associate clinical specialist, Division of Metabolism, Prof. Dr. med. B. Steinmann and Prof. Dr. med. M. Baumgartner, University Children’s Hospital, Zurich, Switzerland 

2015 – 2017 Associated Professor, Division of Metabolism, Prof. Dr. med. M. Baumgartner, University Children’s Hospital, Zurich, Switzerland 

2017 – Head of clinical Program, and Debuty laboratory Head, Diagnostic laboratory, Division of Metabolism, Prof. Dr. med. M. Baumgartner, University Children’s Hospital, Zurich, Switzerland 

Q&A

Stimmen von innen – Stephen Newton – clEDS
USA

Stephen Newton spent his entire teenage and adult life going from physician to physician trying to get answers to the health problems that plagued him. He was finally able to get a diagnosis of clEDS in 2019 from the partnership of his Primary Care Physician and Physical Therapist.  Now, with a coordinated care team as support he is able to pursue his Master’s in Counseling Psychology to try to be able to support those experiencing chronic illnesses. 

Spondylodysplastisches EDS (spEDS) – Dr. Roberto Mendoza-Londono
Toronto

Dr. Mendoza-Londono is head of the Genetics Division of the Hospital for Sick Children and Director of the Ehlers Danlos and Connective Tissue Disorders Program. He holds weekly skeletal dysplasia (SD) clinics and monthly multidisciplinary bone health and connective tissue disorders clinics (CTD). His research focus on the identification of the molecular basis of genetic disorders, delineation of the natural history for patients with SD and CTD, and development of clinical practice guidelines. 

Q&A

Musculokontrakturales EDS (mcEDS) – Dr. Tomoki Kosho
Matsumoto

Tomoki Kosho, MD PhD, is a pediatrician and clinical geneticist. He is a Professor of Department of Medical Genetics, Shinshu University School of Medicine and a Director of Center for Medical Genetics at Shinshu University Hospital, where he manages clinical service for patients with various heritable connective tissue disorders including EDS and also clinical and basic research especially on musculocontractural EDS. 

Myopathisches EDS (mEDS) – Dr. Fleur Van Dijk
London

Fleur van Dijk combines patient care and research in her profession as consultant clinical geneticist. She studies clinical and genetic aspects of hereditary connective tissue disorders. She leads the national diagnostic Ehlers-Danlos service in London North West Healthcare University NHS trust. This is a tertiary service that is aimed at diagnosis and follow-up of people with monogenic types of EDS. The service covers the South of the UK. 

Q&A

Stimmen von innen – Shefaly Begum & Aminur Ahmed – kEDS
UK

Shefaly Begum and Aminur Ahmed are family members of the late Saarah Ahmed who lived with kEDS and tragically passed away on April 13, 2021 aged 20. Saarah was a finalist for Miss Universe GB, and an active advocate within her community and globally. Her goal was to raise awareness to healthcare professionals and the communities about hidden disabilities and Kyphoscoliotic EDS. She was a beautiful person – caring and wise beyond her years. She had so much wisdom. She wanted to go to university to study neurology. She wanted to help other people. Her proud mum, Shefaly Begum and brother, Aminur Ahmed, want to tell Saarah’s story and fulfil her dream of educating people about EDS. 

Orodentale Manifestationen von EDS, parodontales EDS (pEDS) – Prof. Ines Kapferer-Seebacher & Dr. Ulrike Lepperdinger
Innsbruck

Ines Kapferer-Seebacher

Nationality: Austrian 

2000 – License in dental medicine, LMU Munich, Germany 

2002 – Doctoral Thesis, Munich University of Technology, Germany 

2010: Master of Science in periodontics, Medical University Vienna, Austria 

2019: Deputy Head, Department of Operative and Restorative Dentistry, Medical University Innsbruck, Austria 

2020: University Professor for operative dentistry and periodontology 

Ehlers-Danlos Society: Head of the Oral, Mandibular and ENT Manifestation Group 

 Ulrike Lepperdinger

2019 – Dr. med. dent. Thesis and license in dental medicine, Medical University Innsbruck, Austria 

2020- University assistant, Medical University of Innsbruck, Austria 

Oct. 2020-2023 Clinical PhD Training. Topic: Oral Manifestations of Ehlers-Danlos- Syndromes 

Q&A

Seltene EDS – Themen: Kohortenstudien, zukünftige Entwicklungen, allgemeine Themen, EDS Society, Patientenorganisationen

Diese Sitzung wird derzeit verarbeitet und hinzugefügt, sobald sie verfügbar ist.